Pulse Biosciences (PLSE) Capital Expenditures (2015 - 2025)

Pulse Biosciences' Capital Expenditures history runs 11 years deep, the most recent figure standing at $105000.0 for Q4 2025.

• On a quarterly basis, Capital Expenditures rose 238.71% year-over-year to $105000.0 in Q4 2025; TTM through Dec 2025 was $315000.0, a 916.13% increase from a year earlier, with the FY2025 full-year figure at $315000.0, up 916.13% from the prior year.
• Capital Expenditures eased to $105000.0 in Q4 2025 per PLSE's latest filing, from $186000.0 in the prior quarter.
• Across five years, Capital Expenditures topped out at $271000.0 in Q2 2022 and bottomed at -$276000.0 in Q4 2021.
• The 5-year median for Capital Expenditures is $39000.0 (2023), against an average of $47105.3.
• Across the five-year window, Capital Expenditures tumbled 169.57% in 2024 and soared 1262.5% in 2025, its largest moves.
• Year by year, Capital Expenditures stood at -$276000.0 in 2021, then jumped by 114.86% to $41000.0 in 2022, then climbed by 4.88% to $43000.0 in 2023, then slipped by 27.91% to $31000.0 in 2024, then soared by 238.71% to $105000.0 in 2025.
• Per Business Quant, the three latest PLSE Capital Expenditures figures stand at $105000.0 (Q4 2025), $186000.0 (Q3 2025), and -$2000.0 (Q2 2025).